Nowadays, due to a recent histopathologic classification, breast cancer is divided into different subtypes depending on the expression of key proteins such as human epidermal growth factor receptor 2 (HER-2) estrogen and progesterone receptors; Ki67; claudins; epidermal growth factor receptor (EGFR) and others. This evidence concerns the gene ERBB2 and breast carcinoma.